CNW/ - Restaurant Brands International Inc. ("RBI" or the "Company") (TSX: OSR) (NYSE: QSR) announced today that an underwritten registered public ...

Restaurant Brands International Inc. ("RBI" or the "Company") (TSX: QSR) (NYSE: QSR) announced today that Restaurant Brands ...

Capillary Technologies is launching its IPO on November 14, with a price band of ₹549 to ₹577 per share. The ₹877.50 crore ...

Claritev won't sell any shares in the offering or receive any proceeds. The offering is expected to close by Friday. Barclays, Guggenheim Securities and Wells Fargo Securities are acting as joint lead ...

On November 12, 2025, Rollins, Inc. announced the closing of a secondary public offering of 17,391,305 shares of its common stock by existing stockholders LOR, Inc. and Rollins Holding Company, Inc., ...

Rollins, Inc. (NYSE: ROL) ("Rollins" or the "Company") today announced the pricing of a secondary public offering of 17,391,305 shares of its common stock (the "Offering") by LOR, Inc. and Rollins ...

On November 10, 2025, Rollins, Inc. announced a secondary public offering of $1.0 billion of its common stock by existing stockholders LOR, Inc. and Rollins Holding Company, Inc. The company will not ...

Learn how companies issue stock through IPOs and secondary offerings, how the process works, and what it means for everyday investors.

The underwriter proposes to offer the shares of Common Stock from time to time for sale in one or more transactions on the Nasdaq Global Select Market, in the over-the-counter market, through ...

The Estée Lauder Companies Inc. (NYSE: EL) today announces the pricing of the previously announced registered public offering (the “Offering”) of the Company’s Class A Common Stock, par value $.01 per ...

Investors who have applied for the initial public offering (IPO) of Orkla India Limited can check their allotment status ...

Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory ...